A real impediment to the successful treatment of tuberculosis is the development of severe adverse drug reactions, and patients with concurrent HIV infection seem to be particularly at risk. This is shown in our study by the occurrence of Stevens-Johnson syndrome exclusively in patients positive for HIV. It has been widely speculated that thiacetazone is the drug responsible for most of these serious rashes,'4" but this is not yet proved. Hypersensitivity to any antituberculous drug may cause a rash, and studies in which treatment did not include thiacetazone have also shown a greater incidence of adverse drug reactions among patients positive for HIV. 9 16 If, however, it is true that one drug is responsible for most drug reactions then it should be clearly identified so that its use in patients positive for HIV may be avoided.
Another outstanding practical question regarding the management of tuberculosis in the presence of HIV infection is whether, as seems likely, the immune deficiency caused by the virus leads to a greater danger of relapse. Current evidence is preliminary and confficting.9 1017 No difference in HIV prevalence was observed in our study between Design-Prospective study of randomly selected patients with cancer from hospital and the community who were expected to die within a year. Patients expected to live less than two months were interviewed at two week intervals; otherwise patients were interviewed monthly. Their main carer was interviewed three months after the patient's death.
Setting-District general hospital, hospices, and patients' homes.
Main outcome measure-Stated preferred place of final care; actual place of death; reason for final hospital admission for those in hospital; community care provision required for home care.
Results-Of 98 patients approached, 84 (86%) agreed to be interviewed, of whom 70 (83%) died during the study and 59 (84%) stated a preferred place of final care: 34 (58%) wished to die at home given existing circumstances, 12 (20%) in hospital, 12 (20%) in a hospice, and one (2%) elsewhere. Their own home was the preferred place of care for 17 (94%) of the patients who died there, whereas of the 32 patients who died in hospital 22 (69%) had stated a preference to die elsewhere. Had circumstances been more favourable 67% (41) of patients would have preferred to die at home, 16% (10) in hospital, and 15% (9) in hospice.
Conclusion-With a limited increase in community care 50% more patients with cancer could be supported to die at home, as they and their carers would prefer.
Introduction
Place of death and quality of final care are important components of terminal cancer care for both the patient and the family. The proportion of patients with cancer dying at home has fallen steadily in the United Kingdom, from 37% in 1965 to 27% in 1987.' In Edinburgh and Western Australia, however, the provision of cancer care services has enabled as many as 41% and 70% respectively ofpatients with cancer to die at home.23 There are no studies in the United Kingdom reporting patient preferences about place of terminal care.
This study was therefore undertaken to determine prospectively the needs and wishes of patients who were dying from cancer, their symptoms and symptom BMJ VOLUME 301 1 SEPTEMBER 1990 relief,4 where they wished to die, and the resources required for their home and hospital care. (10) to 10% (6) hospital, and 15% (9) to 18% (11) hospice.
Of the 32 who died in hospital, 20 (63%) had stated a final preference to die elsewhere, whereas for the 18 who died at home this was the chosen place for 17 (94%). Hospice was the preferred place for seven (78%) of the nine who died there.
Answers to the questions on future plans were often quite explicit, such as "I hope to go home and will make arrangements to go to a hospice for the end"; "I want to stay at home till the end"; "I have to stay here in hospital while on the antibiotics, then the doctor says I can go home-I'd rather stay here in hospital, but I'm afraid they'll need the bed."
Of the 30 carers who were interviewed three months after the death of their relative and stated an opinion on where he or she had died, 21 (70%) were satisfied. Five carers (28%) of the 18 patients who died in hospital would have preferred to have cared for them at home. Of the 11 carers whose relatives died at home, seven were satisfied; three accepted the patient's wish to die at home, although they thought they would have been Some expansion of health and social service community support for the terminally ill is needed to facilitate policies for those who wish to die at home.9 10 In recognition of this, Harrow Health Authority has now considerably increased community nursing for the dying to include a small team of four Macmillan nurses, a nurse "sitting" service, and provision of equipment. There are at present not as many hospice beds as patients would like, and there is a need for complementary hospital care," 1 such as a small unit of 12 to 15 beds to support the community team, run on a hospice basis'0'6 to provide necessary inpatient palliative and terminal care, including provision for relatives. This would alleviate some of the inevitable problems of caring for dying patients on a busy acute ward.8 1012 14 The cost would be considerably less than that of the acute beds used at present.
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